Live Quote · OTCATRXHealthcare· Medical - Pharmaceuticals

Adhera Therapeutics Inc

$0.00 0.00%(+$0.00)
TickerSpark Score
52/100
Mixed
100
Valuation
35
Profitability
60
Growth
36
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ATRX research report →

52-Week Range0% of range
Low
$0.00
Current
$0.00
High
$0.01
Company Overviewadherathera.com

About the company

Adhera Therapeutics, Inc. , a biotech company, focuses on the discovery, development, and commercialization of small molecule drugs. The company is developing MLR-1019 for the treatment of Parkinson’s disease; and MLR -1023 to treat Type 1 diabetes.

CEO
David A. Battat
IPO
1993
Employees
2
HQ
Baton Rouge, LA, US

Price Chart

+0.00% · this period
$0.01$0.01$0.00Jul 02Dec 31Jul 02
Valuation
Market Cap
$722
P/E
-0.00
P/S
0.00
P/B
-0.00
EV/EBITDA
-5.29
Div Yield
0.00%
Profitability
Gross Margin
0.00%
Op Margin
0.00%
Net Margin
0.00%
ROE
8.94%
ROIC
11.90%
Growth & Income
Revenue
$0 · 0.00%
Net Income
$-2,114,000 · 66.71%
EPS
$-1.18 · 90.81%
Op Income
$-1,618,000
FCF YoY
-112.78%
Performance & Tape
52W High
$0.01
52W Low
$0.00
50D MA
$0.00
200D MA
$0.00
Beta
873.86
Avg Volume
116

Get TickerSpark's AI analysis on ATRX

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Apr 20, 21Waerness Trond Kyddother0
Nov 5, 21Subhan Zahedother0
Jul 7, 20KUCHARCHUK ANDREW ALBERTother0
Nov 1, 19Stanley Rhonda L.other350,000
Nov 1, 19Stanley Rhonda L.other0
Apr 4, 19Phelan Nancy R.other1,500,000
Jan 15, 19Teague Robert Ericother100,000
Oct 1, 18Phelan Nancy R.other0
Oct 1, 18Trieu Vuongsell500,000
Sep 24, 18Teague Robert Ericother0
Coverage · ATRX

Our ATRX coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on ATRX yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate ATRX report →
Internal Compare

Similar companies

Peers in the same neighborhood.